Archives

by in
Entry Author Date Location
Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans 02/09/15 Boston
More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal 01/13/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software 12/16/14 New York
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines 03/10/14 Seattle
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
Using Cutting-Edge Science and Technology Against an Age-Old Disease 01/24/14 Seattle
Madison Vaccines Closes $8M Series A Round for Prostate Treatment 01/13/14 Wisconsin
Vaccine Developer Genocea Files For IPO, Plans to Raise $75M 12/23/13 Boston
IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up 12/19/13 Seattle
San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More 12/19/13 San Diego
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2) 11/26/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Genocea’s Herpes Vaccine Heads For Critical Proving Ground 09/12/13 Boston
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More 08/15/13 San Diego
Theraclone Merges With PharmAthene, Plans to Stay in Seattle 08/01/13 Seattle
Ex-Prometheus Exec Takes the Reins at Dallas’ Gradalis 07/23/13 Texas
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Inviragen, Global Health Vaccine Maker, Bought by Takeda for $35M 05/08/13 Boulder/Denver
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
Protein Sciences’ Pitch: a “Pure” Flu Vaccine Alternative 03/11/13 New York
Page 1 of 9 next page »